Tech Company Financing Transactions

Senti Biosciences Funding Round

Senti Biosciences closed a $53 million Series A venture capital round on 2/28/2018. Investors included New Enterprise Associates, 8VC and Allen & Company.

Transaction Overview

Company Name
Announced On
2/28/2018
Transaction Type
Venture Equity
Amount
$53,000,000
Round
Series A
Proceeds Purpose
This funding round will accelerate the scaling of our genetic circuit programming platform and its translation into clinical treatments.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Corporate Dr. 1st Floor 750
San Francisco, CA 94080
USA
Phone
Undisclosed
Email Address
Overview
Senti Biosciences is a team of bioengineers, scientists, and entrepreneurs on a mission to treat the most complex and challenging diseases.
Profile
Senti Biosciences LinkedIn Company Profile
Social Media
Senti Biosciences Company Twitter Account
Company News
Senti Biosciences News
Facebook
Senti Biosciences on Facebook
YouTube
Senti Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Lu
  Timothy Lu LinkedIn Profile  Timothy Lu Twitter Account  Timothy Lu News  Timothy Lu on Facebook
Chief Financial Officer
Curt Herberts
  Curt Herberts LinkedIn Profile  Curt Herberts Twitter Account  Curt Herberts News  Curt Herberts on Facebook
Chief Medical Officer
Jose´ Iglesias
  Jose´ Iglesias LinkedIn Profile  Jose´ Iglesias Twitter Account  Jose´ Iglesias News  Jose´ Iglesias on Facebook
Chief Operating Officer
Philip Lee
  Philip Lee LinkedIn Profile  Philip Lee Twitter Account  Philip Lee News  Philip Lee on Facebook
Chief Scientific Officer
Gary Lee
  Gary Lee LinkedIn Profile  Gary Lee Twitter Account  Gary Lee News  Gary Lee on Facebook
Co-Founder
James Collins
  James Collins LinkedIn Profile  James Collins Twitter Account  James Collins News  James Collins on Facebook
Co-Founder
Wilson Wong
  Wilson Wong LinkedIn Profile  Wilson Wong Twitter Account  Wilson Wong News  Wilson Wong on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/28/2018: CyberX venture capital transaction
Next: 2/28/2018: SteroTherapeutics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary